Table 4.
Change in inflammatory markers of the study participants in intervention and control groups (n = 169)
| Variables | Intervention group | Control group | Between-group difference (95% CI) | p value† | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Baseline (n = 86) | End of 12 weeks (n = 86) | Change | *p value | Baseline (n = 83) | End of 12 weeks (n = 83) | Change | *p value | |||
| hs-CRP (mg/L) | 5.5 ± 0.6 | 5.5 ± 0.8 | 0.0 ± 0.7 | 0.94 | 6.7 ± 0.7 | 7.8 ± 0.8 | 1.1 ± 0.7 | 0.23 | − 1.1 (− 3.4, 0.8) | 0.24 |
| TNFα (pg/ml) | 213 ± 24 | 238 ± 39 | 25 ± 37 | 0.26 | 213 ± 25 | 311 ± 40 | 98 ± 38 | 0.05 | 73.3 (− 178.1, 31.4) | 0.17 |
Data presented as least square mean ± standard deviation
*p value < 0.05 is considered significant using the paired t test
†p value < 0.05 is considered as significant using generalized linear model (GLM)